BRONCUS HOLDING CORPORATION Financials Broncus Holding Corporation
Equities
2216
KYG1609T1022
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.53 HKD | -1.85% |
|
-1.85% | -32.91% |
| Apr. 22 | Broncus Chairman Resigns; Successor Named | MT |
| Apr. 19 | Broncus Holding Corporation Announces Changes to Its Board | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 607.9 | 154.5 | 36.37 | 36.37 | - |
| Enterprise Value (EV) 1 | 382.6 | 49.21 | 53.34 | 36.37 | 36.37 |
| P/E ratio | -1.46 x | -4.89 x | -1.69 x | - | - |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 55.8 x | 16.4 x | 5.2 x | 2.79 x | 2.14 x |
| EV / Revenue | 55.8 x | 16.4 x | 5.2 x | 2.79 x | 2.14 x |
| EV / EBITDA | -16.5 x | -5.18 x | -1.72 x | -12 x | 15.2 x |
| EV / FCF | -18.2 x | - | -1.45 x | -6.06 x | - |
| FCF Yield | -5.49% | - | -68.7% | -16.5% | - |
| Price to Book | 1.42 x | - | 0.2 x | 0.2 x | 0.2 x |
| Nbr of stocks (in thousands) | 526,561 | 526,873 | 527,198 | 527,198 | - |
| Reference price 2 | 1.154 | 0.2932 | 0.0690 | 0.0690 | 0.0690 |
| Announcement Date | 3/29/22 | 3/29/23 | 3/28/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | 10.89 | 9.413 | 10.26 | 13.03 | 17.03 |
| EBITDA 1 | -36.92 | -29.84 | -30.96 | -3.03 | 2.4 |
| EBIT 1 | -39.27 | -32.27 | -33.34 | -5 | 1 |
| Operating Margin | -360.56% | -342.82% | -325.13% | -38.37% | 5.87% |
| Earnings before Tax (EBT) 1 | -236.2 | -28.03 | -28.09 | - | - |
| Net income 1 | -235.8 | -28.04 | -28.09 | - | - |
| Net margin | -2,164.94% | -297.84% | -273.93% | - | - |
| EPS 2 | -0.7900 | -0.0600 | -0.0600 | - | - |
| Free Cash Flow 1 | -33.35 | - | -25 | -6 | - |
| FCF margin | -306.21% | - | -164.58% | -46.05% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 3/29/22 | 3/29/23 | 3/28/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 |
|---|---|---|---|---|
| Net sales 1 | 8.038 | 3.218 | 6.195 | 5.234 |
| EBITDA | - | - | - | - |
| EBIT 1 | -16.15 | -16.24 | -16.03 | -17.18 |
| Operating Margin | -200.95% | -504.57% | -258.81% | -328.24% |
| Earnings before Tax (EBT) | - | - | - | - |
| Net income | - | - | - | - |
| Net margin | - | - | - | - |
| EPS 2 | - | -0.0300 | -0.0300 | -0.0300 |
| Dividend per Share | - | - | - | - |
| Announcement Date | 3/29/22 | 8/30/22 | 3/29/23 | 8/29/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | 225 | 105 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 1 | -33.3 | - | -25 | -6 | - |
| ROE (net income / shareholders' equity) | -387% | -12.3% | -12.8% | -2.34% | 0.26% |
| ROA (Net income/ Total Assets) | -161% | -11.8% | -12.2% | -2.21% | 0.24% |
| Assets 1 | 146.3 | 237.4 | 208.8 | - | - |
| Book Value Per Share 2 | 0.8100 | - | 0.3500 | 0.3400 | 0.3400 |
| Cash Flow per Share | -0.1100 | - | - | - | - |
| Capex 1 | 1.86 | - | 1.7 | 1.94 | 2.03 |
| Capex / Sales | 17.03% | - | 11.19% | 14.89% | 11.92% |
| Announcement Date | 3/29/22 | 3/29/23 | 3/28/24 | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.069
USD
Average target price
0.137
USD
Spread / Average Target
+98.61%
| 1st Jan change | Capi. | |
|---|---|---|
| -32.91% | 36.37M | |
| -5.77% | 14.6B | |
| -40.71% | 2.71B | |
| -12.92% | 2.44B | |
| -8.78% | 1.51B | |
| -.--% | 1.12B | |
| +40.66% | 518M | |
| +11.68% | 239M | |
| +1.67% | 183M | |
| -.--% | 168M |
- Stock Market
- Equities
- 2216 Stock
- Financials Broncus Holding Corporation
